Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

KyungAh Im

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Diabetes, Obesity & Metabolism|February 10, 2017
Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR-TIMI 53 outcome studyAvivit Cahn, Ofri Mosenzon, Deepak L Bhatt, et al.
Clinical Cardiology|June 18, 2022
Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitorsBenjamin M Scirica, KyungAh Im, Sabina A Murphy, et al.
Circulation|July 9, 2015
Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) RegistryMatthew A Cavender, Ph Gabriel Steg, Sidney C Smith, et al.
Diabetes Care|June 11, 2014
Incidence of pancreatitis and pancreatic cancer in a randomized controlled multicenter trial (SAVOR-TIMI 53) of the dipeptidyl peptidase-4 inhibitor saxagliptinItamar Raz, Deepak L Bhatt, Boaz Hirshberg, et al.
JAMA Cardiology|December 8, 2017
Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 TrialBenjamin M Scirica, Ofri Mosenzon, Deepak L Bhatt, et al.
Circulation|August 1, 2019
Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 TrialBrian A Bergmark, Deepak L Bhatt, Darren K McGuire, et al.
European Heart Journal|November 11, 2022
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54Marc P Bonaca, KyungAh Im, Giulia Magnani, et al.
Journal of Hepatology|June 24, 2008
Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis CXiaowen Su, Leland J Yee, KyungAh Im, et al.
Journal of the American College of Cardiology|May 9, 2020
Cognition After Lowering LDL-Cholesterol With EvolocumabBaris Gencer, François Mach, Jianping Guo, et al.
Journal of the American College of Cardiology|April 6, 2016
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54Deepak L Bhatt, Marc P Bonaca, Sameer Bansilal, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Diabetes, Obesity & Metabolism|February 10, 2017
Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR-TIMI 53 outcome studyAvivit Cahn, Ofri Mosenzon, Deepak L Bhatt, et al.
Clinical Cardiology|June 18, 2022
Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitorsBenjamin M Scirica, KyungAh Im, Sabina A Murphy, et al.
Circulation|July 9, 2015
Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) RegistryMatthew A Cavender, Ph Gabriel Steg, Sidney C Smith, et al.
Diabetes Care|June 11, 2014
Incidence of pancreatitis and pancreatic cancer in a randomized controlled multicenter trial (SAVOR-TIMI 53) of the dipeptidyl peptidase-4 inhibitor saxagliptinItamar Raz, Deepak L Bhatt, Boaz Hirshberg, et al.
JAMA Cardiology|December 8, 2017
Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 TrialBenjamin M Scirica, Ofri Mosenzon, Deepak L Bhatt, et al.
Circulation|August 1, 2019
Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 TrialBrian A Bergmark, Deepak L Bhatt, Darren K McGuire, et al.
European Heart Journal|November 11, 2022
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54Marc P Bonaca, KyungAh Im, Giulia Magnani, et al.
Journal of Hepatology|June 24, 2008
Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis CXiaowen Su, Leland J Yee, KyungAh Im, et al.
Journal of the American College of Cardiology|May 9, 2020
Cognition After Lowering LDL-Cholesterol With EvolocumabBaris Gencer, François Mach, Jianping Guo, et al.
Journal of the American College of Cardiology|April 6, 2016
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54Deepak L Bhatt, Marc P Bonaca, Sameer Bansilal, et al.
Pageof 8